June 2026
You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get StartedGOCOVRI® (amantadine) Ex... Market Share Analysis for June 2026
gocovri® (amantadine) an extended-release treatment for both dyskinesia and off time in patients with parkinson’s disease. see safety & prescribing information.
GOCOVRI® (amantadine) Extended Releas... (including company regionals)
See more website traffic and engagement information- gocovri.com
Total visits to GOCOVRI® (amantadine) Extended Releas...'s top domains
Understand GOCOVRI® (amantadine) Extended Releas... market share and potential market reach.
Total visits last 3 months
Subsidiaries Breakdown
Avg. visit duration in GOCOVRI® (amantadine) Extended Releas...'s top domains
Analyze GOCOVRI® (amantadine) Extended Releas... engagement metrics.
Average visit duration last 3 months
Subsidiaries Breakdown
Avg. pageviews on GOCOVRI® (amantadine) Extended Releas...'s top domains
See how GOCOVRI® (amantadine) Extended Releas... keep users engaged, nurture their interest, and encourage them to take the next step.
Average page views last 3 months
Subsidiaries Breakdown
